1. Optimal therapeutic positioning of a selective bi-steric inhibitor of MTORC1 in genetically defined cancers. (October 2020) Authors: Jiang, J.; Yang, Y.C.; Schulze, C.J.; Evans, J.W.; Wang, Z.C.; Lee, B.J.; Choy, T.J.; Reyes, D.F.; Zhao, R.P.; Tao, J.Y.; Du, H.; Ozawa, T.; Wildes, D.P.; Raleigh, D.R.; Wang, Z.P.; Monga, S.P.; Kwiatkowski, D.J.; Weiss, W.A.; Smith, J.A.; Singh, M. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 2 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗